Project News Detail

Project No :174377
Project Title :Formulations Manufacturing Project In Telangana
Company Name : Shilpa Medicare Limited
Project Detail :US FDA has issued an Establishment Inspection Report (EIR) for Shilpa Medicare Ltd's formulations manufacturing facility (SEZ unit) located at Jadcherla, Telangana, India which was inspected between 11th November and 30th November 2017. FDA has determined that the inspection classification of this facility is VAI and accordingly EIR issued
Project Location : Not Classified - Telangana - India
Project Industry :Drugs and Pharmaceuticals
Project Estimation :Refer Document
Status :Announced
Top